View Post

Propanc Biopharma Initiates Development of Bio-Analytical Assay in Preparation for Human Trials

In Clinical Trials by Barbara Jacoby

From: prnewswire.com Feasibility Study Intends to Quantify PRP’s Active Ingredients in Human Serum Propanc Biopharma, Inc. (OTCQB: PPCB) (“Propanc”), a biopharmaceutical company developing new cancer treatments for patients suffering from recurring and metastatic cancer, announced today that it has initiated development of a bio-analytical assay intended to quantify the active ingredients of the company’s lead product candidate, PRP, in preparation …

View Post

The cost of medication: Prices that are too low could reduce access

In In The News by Barbara Jacoby

SOURCE: Montreal Economic Institute From: Canada NewsWire If Health Canada achieves its goal of lowering the maximum prices for drugs, the health of Canadians could suffer, shows a Viewpoint published today by the MEI. Indeed, in countries that have implemented similar price control policies, new drugs have become less accessible to the population. “In wanting to reduce the prices of …

View Post

FDA takes action against 14 companies for selling illegal cancer treatments

In In The News by Barbara Jacoby

From: PR Newswire The U.S. Food and Drug Administration today posted warning letters addressed to 14 U.S.-based companies illegally selling more than 65 products that fraudulently claim to prevent, diagnose, treat or cure cancer. The products are marketed and sold without FDA approval, most commonly on websites and social media platforms. “Consumers should not use these or similar unproven products …

View Post

Biosimilars create opportunities for sustainable cancer care

In In The News by Barbara Jacoby

Biosimilars create opportunities for sustainable cancer care, says the European Society for Medical Oncology (ESMO) in a position paper published in ESMO Open.1 The document outlines approval standards for biosimilars, how to safely introduce them into the clinic, and the potential benefits for patients and healthcare systems. “Biosimilars are an excellent opportunity to have good, valid drug options that improve …

View Post

Females Suffer From Gender Gap in Cancer Trials, Drug Development

In In The News by Barbara Jacoby

By: Jessica Firger From: newsweek.com Identifying effective cancer treatments is never an easy process, and even drugs that make it to the market are rarely effective on every patient. As cancer treatment becomes more personalized, clinicians have come to realize how biological factors beyond a patient’s control—especially gender—can determine treatment outcome. Oncologists often know a treatment may fail, not based …

View Post

Too Many ‘Me-Too’ Cancer Drugs? FDA Official Asks

In In The News by Barbara Jacoby

By: Deena Beasley, Reuters From: nbcnews.com A new type of cancer drug that takes the brakes off the body’s immune system has given drugmakers some remarkable wins against the deadly disease, but a top U.S. regulator says too many companies are focused on the same approach. The therapies, designed to disable the PD-1 protein that tumors use to evade the …

View Post

Tests for new cancer drugs not reliable enough, doctors say

In In The News by Barbara Jacoby

From: reuters.com Drugmakers including Bristol-Myers Squibb Co and Merck & Co are testing which patients will most benefit from new cancer treatments based on a protein found in their tumors, but that guide, known as a biomarker, may be too unreliable, researchers and health experts said. Bristol’s Opdivo and Merck’s Keytruda are both therapies designed to block a protein known …

More Bridges, More Options in Cancer Treatment – ASCO 2013 Wrap Up

In In The News, Uncategorized by Barbara Jacoby

POSTED IN Blog, Healthcare, Pharma The ASCO 2013 Annual Meeting has come to a close and the over 25,000 attendees have returned home armed with new ideas around the advances in cancer treatment. The conference highlighted immunotherapies, breakthrough drugs and difficult issues facing the oncology community. Immunotherapies were the hottest new topic in oncotherapy development, you expect to hear much …

You Have Cancer? What Next?

In Breast Cancer, Recent Posts by Barbara Jacoby

You’ve just heard those three words from your doctor, “You have cancer”, and you know that your life will be changed forever.  Now what?  If you are like me, you will do what your doctor tells you to do as you speed through all of the testing and preparation for round one of either treatment or surgery.  And before you …